levamisole has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, L; Kuzhikandathil, EV; Li, Y | 1 |
| Galluzzo, A | 1 |
| Strausser, HR; Warchalowski, GA | 1 |
1 review(s) available for levamisole and Alloxan Diabetes
| Article | Year |
|---|---|
[Immunotherapy in type 1 (insulin-dependent) diabetes].
Topics: Animals; Bone Marrow Transplantation; Child; Cyclosporins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Humans; Immunosuppressive Agents; Immunotherapy; Inosine Pranobex; Interferon Type I; Levamisole; Plasmapheresis; Prednisone; Rats; Thymectomy | 1984 |
2 other study(ies) available for levamisole and Alloxan Diabetes
| Article | Year |
|---|---|
The extracellular cAMP-adenosine pathway regulates expression of renal D1 dopamine receptors in diabetic rats.
Topics: Adenosine; Alkaline Phosphatase; Animals; Antirheumatic Agents; Cyclic AMP; Diabetes Mellitus, Experimental; Down-Regulation; Kidney; Levamisole; Male; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine | 2011 |
Altered immune reactivity in encephalomyocarditis-M variant (EMC-M)-induced diabetes in mice.
Topics: Animals; Antilymphocyte Serum; Concanavalin A; Diabetes Mellitus, Experimental; Encephalomyocarditis virus; Enterovirus Infections; Genetic Variation; Glycosuria; Immunosuppression Therapy; Indomethacin; Levamisole; Male; Mice; Mice, Inbred DBA; Phytohemagglutinins; Pokeweed Mitogens | 1979 |